Zaytsev Evgeny 4

What Happened
Evgeny Zaytsev, a director of CalciMedica, received a derivative award of 20,000 shares on July 2, 2026. The filing reports the acquisition price as $0.00 (i.e., a grant/award rather than an open-market purchase), so there was no cash outlay recorded in the Form 4.

Key Details

• Transaction date: 2026-07-02; Form 4 filed/posted: 2026-07-07 (Accession: 0001674797-26-000004).
• Transaction type: Grant / award (derivative). Reported amount: 20,000 shares at $0.00.
• Vesting: Footnote states 1/36th of the shares subject to the option vest in equal monthly installments over a three-year period following the grant date.
• Shares owned after the transaction: not specified in the provided summary; see the Form 4 for the insider’s total holdings.
• No 10b5-1, tax-withholding, or late-filing flag noted in the provided data — check the full filing for any timeliness or procedural notes.

Context
This was an awarded derivative grant (commonly stock options or RSUs) that vests over time; it is compensation-oriented and not an immediate purchase or sale. Such grants align insiders’ interests with shareholders but do not necessarily indicate an immediate bullish or bearish market signal until/if shares are exercised or sold.